Materials • Major Chemicals
$66.01 ▲ +0.18
(+0.27%)
MKT CAP: $8.44B • VOL: 916.0K
52W L $56 52W H $124
WLK // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $11.17B | $12.14B | $12.55B |
| YoY Revenue Growth % | -8.0% | -3.2% | — |
| Gross Profit | $813.0M | $1.96B | $5.52B |
| Gross Margin % | 7.3% | 16.1% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$1.58B | $875.0M | $729.0M |
| Operating Margin % | -14.1% | 7.2% | 5.8% |
| Net Income (GAAP) | -$1.51B | $602.0M | $479.0M |
| EBITDA (Normalized) | -$782.0M | $1.68B | $1.18B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $465.0M | $1.31B | $2.34B |
| Capital Expenditures (CapEx) | $995.0M | $1.01B | $564.7M |
| Free Cash Flow (FCF) | -$530.0M | $306.0M | $1.77B |
| FCF Margin % | -4.7% | 2.5% | 14.1% |
| Return on Invested Capital (ROIC %) | -11.2% | 5.7% | 6.3% |
| Cash & Short-Term Equivalents | $2.72B | $2.92B | $1.66B |
| Total Debt (Short + Long Term) | $5.09B | $4.56B | $3.52B |
| Total Stockholders' Equity | $8.79B | $10.53B | $7.23B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR WLK.